d-alpha tocopherol has been researched along with Adverse Drug Event in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (27.27) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (9.09) | 29.6817 |
| 2010's | 12 (54.55) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| De Serres, G; Drolet, JP; Gagnon, R; Landry, M; Ménard, S; Ouakki, M; Rouleau, I; Skowronski, DM; Toth, E | 1 |
| Berglund, J; Boutriau, D; Lestrate, P; Tavares Da Silva, F; Vink, P | 1 |
| Drame, M; Frenette, L; Godeaux, O; Innis, BL; Izurieta, P; Jeanfreau, R; Kosalaraksa, P; Madariaga, M; Vaughn, DW | 1 |
| Boutriau, D; Damaso, S; Haelterman, E; Lestrate, P; Levy, J; Licini, L; Moris, P; Van Belle, P | 1 |
| Ferguson, M; Frenette, L; Friel, D; Innis, BL; Kroll, R; Li, P; Madan, A; Schuind, A; Segall, N; Soni, J | 1 |
| Chu, L; Ferguson, M; Friel, D; Innis, BL; Li, P; Madan, A; Rheault, P; Schuind, A; Segall, N; Sheldon, E; Soni, J; Toma, A | 1 |
| Ferguson, M; Friel, D; Innis, BL; Li, P; Madan, A; Rheault, P; Schuind, A; Seiden, D; Soni, J; Toma, A | 1 |
| Dobson, S; Halperin, SA; Kellner, JD; Kollman, T; Kuhn, S; Langley, JM; Li, Y; MacKinnon-Cameron, D; McNeil, S; Quach, C; Scheifele, DW; Smith, B; Vanderkooi, OG; Ward, B | 1 |
| Chu, L; Frenette, L; Halperin, S; Langley, JM; Li, P; McNeil, S; Vaughn, D | 1 |
| Ferraresi, A; Fetoni, AR; Paludetti, G; Scarano, E; Sergi, B; Troiani, D | 1 |
| Chen, Z; Niki, E; Piga, R; Saito, Y; Yoshida, Y | 1 |
| Lowery, J; Patel, H; Shirk, D | 1 |
| Campagna, G; Capobianco, D; Costagliola, C; Marino, PF; Rossi, GCM | 1 |
| Abdelaziz, I; Ashour, Ael R | 1 |
| Béduneau, A; Lamprecht, A; Maupas, C; Moulari, B; Pellequer, Y | 1 |
| Anderson, K; Arnold, KB; Baker, LH; Cook, ED; Crowley, JJ; Darke, AK; Goodman, PJ; Hartline, JA; Klein, EA; Meyskens, FL; Minasian, LM; Tangen, CM; Yee, M | 1 |
| Szukalski, B | 1 |
| Corcoran, GB; Hughes, H; Lauterburg, BH; Mitchell, JR; Smith, CV | 1 |
| Ramirez, A | 1 |
| Paranich, AV; Soloshenko, EN | 1 |
| Wurm, K | 1 |
3 review(s) available for d-alpha tocopherol and Adverse Drug Event
| Article | Year |
|---|---|
[Physiological and toxicological aspects of metabolic activation of drugs].
Topics: Antioxidants; Biotransformation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Fatty Acids, Unsaturated; Free Radicals; Humans; Hydrogen Peroxide; Lipid Peroxides; NADPH-Ferrihemoprotein Reductase; Oxidation-Reduction; Pharmaceutical Preparations; Superoxides; Vitamin E | 1984 |
The neonate's unique response to drugs: unraveling the causes of drug iatrogenesis.
Topics: Chloramphenicol; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Humans; Infant, Newborn; Infant, Newborn, Diseases; Pharmacokinetics; Preservatives, Pharmaceutical; Vitamin E | 1989 |
[Therapy of sarcoidosis].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Antineoplastic Agents; Chloroquine; Drug-Related Side Effects and Adverse Reactions; Humans; Isoniazid; Male; Sarcoidosis; Vitamin E | 1966 |
9 trial(s) available for d-alpha tocopherol and Adverse Drug Event
| Article | Year |
|---|---|
Safety, immunogenicity, and antibody persistence following an investigational Streptococcus pneumoniae and Haemophilus influenzae triple-protein vaccine in a phase 1 randomized controlled study in healthy adults.
Topics: Adjuvants, Immunologic; Adolescent; Adult; alpha-Tocopherol; Antibodies, Bacterial; CD4-Positive T-Lymphocytes; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Haemophilus Vaccines; Humans; Male; Pneumococcal Vaccines; Polysorbates; Squalene; Vaccination; Vaccines, Combined; Vaccines, Subunit; Vaccines, Synthetic; Young Adult | 2014 |
AS03B-adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo-controlled, observer-blinded trial.
Topics: Adjuvants, Immunologic; Adolescent; alpha-Tocopherol; Antibodies, Viral; Child; Child, Preschool; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant; Influenza A Virus, H5N1 Subtype; Influenza Vaccines; Influenza, Human; Male; Placebos; Polysorbates; Single-Blind Method; Squalene; Treatment Outcome; Vaccination; Vaccines, Inactivated | 2015 |
Safety and immunogenicity of an investigational 4-component Staphylococcus aureus vaccine with or without AS03B adjuvant: Results of a randomized phase I trial.
Topics: Adjuvants, Immunologic; Adolescent; Adult; alpha-Tocopherol; Antibodies, Bacterial; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Healthy Volunteers; Humans; Male; Placebos; Polysorbates; Single-Blind Method; Squalene; Staphylococcal Infections; Staphylococcal Vaccines; Young Adult | 2015 |
Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults.
Topics: Adjuvants, Immunologic; Adolescent; Adult; alpha-Tocopherol; Antibodies, Viral; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Healthy Volunteers; Humans; Immunization Schedule; Influenza A Virus, H7N9 Subtype; Influenza Vaccines; Influenza, Human; Male; Middle Aged; Placebos; Polysorbates; Single-Blind Method; Squalene; Vaccines, Inactivated; Young Adult | 2016 |
Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in healthy adults: A phase I/II, observer-blind, randomized, controlled trial.
Topics: Adaptive Immunity; Adjuvants, Immunologic; Adult; alpha-Tocopherol; Animals; Antibodies, Viral; Canada; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Healthy Volunteers; Hemagglutination Inhibition Tests; Humans; Influenza A Virus, H7N1 Subtype; Influenza Vaccines; Influenza, Human; Male; Middle Aged; Neutralization Tests; Placebos; Polysorbates; Single-Blind Method; Squalene; United States; Vaccines, Inactivated; Young Adult | 2017 |
Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in adults 65years of age and older: A phase II, observer-blind, randomized, controlled trial.
Topics: Adult; Aged; Aged, 80 and over; alpha-Tocopherol; Animals; Antibodies, Neutralizing; Antibodies, Viral; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Healthy Volunteers; Hemagglutination Inhibition Tests; Humans; Influenza A Virus, H7N1 Subtype; Influenza Vaccines; Male; Neutralization Tests; Placebos; Polysorbates; Single-Blind Method; Squalene; Vaccines, Inactivated | 2017 |
Safety and immunogenicity of 2010-2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12-59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: a PHAC/CIHR Influenza Research Network (PCIRN) study.
Topics: Adjuvants, Immunologic; alpha-Tocopherol; Antibodies, Viral; Canada; Child, Preschool; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Interviews as Topic; Male; Polysorbates; Prospective Studies; Squalene; Vaccines, Inactivated | 2012 |
A randomized, controlled non-inferiority trial comparing A(H1N1)pmd09 vaccine antigen, with and without AS03 adjuvant system, co-administered or sequentially administered with an inactivated trivalent seasonal influenza vaccine.
Topics: Adjuvants, Immunologic; Adult; alpha-Tocopherol; Antibodies, Viral; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Influenza Vaccines; Influenza, Human; Male; Polysorbates; Squalene; Vaccination; Young Adult | 2012 |
Moving a randomized clinical trial into an observational cohort.
Topics: Adult; Aged; Aged, 80 and over; Canada; Clinical Trials Data Monitoring Committees; Cohort Studies; Data Collection; Dietary Supplements; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Follow-Up Studies; Humans; Male; Middle Aged; National Cancer Institute (U.S.); Placebos; Prostatic Neoplasms; Puerto Rico; Randomized Controlled Trials as Topic; Research Design; Selenium; United States; Vitamin E | 2013 |
10 other study(ies) available for d-alpha tocopherol and Adverse Drug Event
| Article | Year |
|---|---|
Increased risk of anaphylaxis following administration of 2009 AS03-adjuvanted monovalent pandemic A/H1N1 (H1N1pdm09) vaccine.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Aged, 80 and over; alpha-Tocopherol; Anaphylaxis; Canada; Child; Child, Preschool; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Male; Middle Aged; Polysorbates; Quebec; Risk Assessment; Squalene; Young Adult | 2013 |
Protective effects of alpha-tocopherol against gentamicin-induced Oto-vestibulo toxicity: an experimental study.
Topics: alpha-Tocopherol; Animals; Auditory Threshold; Disease Models, Animal; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Ear, Inner; Evoked Potentials, Auditory, Brain Stem; Female; Gentamicins; Guinea Pigs; Hearing Loss; Male; Microscopy, Electron, Scanning; Probability; Reference Values; Reflex, Vestibulo-Ocular; Vestibule, Labyrinth | 2003 |
Characterization of monochloramine toxicity on PC12 cells and protective effect of tocopherol via antioxidative function.
Topics: alpha-Tocopherol; Animals; Antioxidants; beta-Tocopherol; Caspases; Cell Death; Chloramines; DNA Damage; Drug-Related Side Effects and Adverse Reactions; Enzyme Activation; Fluoresceins; PC12 Cells; Phosphatidylserines; Rats; Reactive Oxygen Species; Tocopherols; Tumor Cells, Cultured | 2005 |
Topics: Adolescent; Chemical and Drug Induced Liver Injury; Drug-Related Side Effects and Adverse Reactions; Humans; Intellectual Disability; Male; Olanzapine; Stress Disorders, Post-Traumatic; Vitamin E | 2020 |
Effects of Citicoline, Homotaurine, and Vitamin E on Contrast Sensitivity and Visual-Related Quality of Life in Patients with Primary Open-Angle Glaucoma: A Preliminary Study.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antioxidants; Contrast Sensitivity; Cross-Over Studies; Cytidine Diphosphate Choline; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Glaucoma, Open-Angle; Humans; Male; Middle Aged; Neuroprotective Agents; Pilot Projects; Quality of Life; Random Allocation; Surveys and Questionnaires; Taurine; Vitamin E | 2020 |
Effect of saccharin on albino rats' blood indices and the therapeutic action of vitamins C and E.
Topics: Animals; Antioxidants; Ascorbic Acid; Blood Chemical Analysis; Drug-Related Side Effects and Adverse Reactions; Female; Hematologic Tests; Rats; Saccharin; Sweetening Agents; Vitamin E | 2011 |
Surfactant dependent toxicity of lipid nanocapsules in HaCaT cells.
Topics: Cell Line; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Stability; Drug-Related Side Effects and Adverse Reactions; Humans; Keratinocytes; Lipids; Nanocapsules; Pharmaceutical Preparations; Polyethylene Glycols; Skin; Surface-Active Agents; Vitamin E | 2011 |
Alkylation and peroxidation injury from chemically reactive metabolites.
Topics: Acetaminophen; Acetylcysteine; Alkylation; Animals; Antioxidants; Biotransformation; Drug-Related Side Effects and Adverse Reactions; Glutathione; Glutathione Disulfide; Humans; Lipid Peroxides; Liver; Microsomes, Liver; Peroxides; Pharmaceutical Preparations; Vitamin E | 1981 |
[Pathogenetic significance of a decrease in the alpha-tocopherol level in drug-induced disease].
Topics: Adult; Aged; Chronic Disease; Drug Eruptions; Drug Hypersensitivity; Drug-Related Side Effects and Adverse Reactions; Humans; Middle Aged; Vitamin E | 1987 |
Pharmacogenetics and therapeutic surveillance.
Topics: Adolescent; Anemia, Hemolytic; Antidepressive Agents, Tricyclic; Child; Child, Preschool; Depression; Drug-Related Side Effects and Adverse Reactions; Egypt; Ethnicity; Glucosephosphate Dehydrogenase Deficiency; Humans; Infant; Infant, Newborn; Kinetics; Male; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic; Vitamin E | 1985 |